Why the Johnson & Johnson Vaccine Has Gotten a Bad Rap–And Why That’s Not Fair

February 23, 2021

(NPR) – Two COVID-19 vaccines are being distributed in the U.S. right now, and this week an FDA advisory committee will vote on whether a third should join them. If granted emergency use authorization, Johnson & Johnson’s one-dose vaccine would become available in the U.S., along with those from Pfizer and Moderna.